(NASDAQ: TBIO) Telesis Bio's forecast annual revenue growth rate of 82.9% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.66%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.
Telesis Bio's revenue in 2023 is $21,044,000.On average, 3 Wall Street analysts forecast TBIO's revenue for 2023 to be $1,322,574,714, with the lowest TBIO revenue forecast at $1,018,500,617, and the highest TBIO revenue forecast at $1,579,414,000. On average, 1 Wall Street analysts forecast TBIO's revenue for 2024 to be $3,442,236,866, with the lowest TBIO revenue forecast at $3,442,236,866, and the highest TBIO revenue forecast at $3,442,236,866.
In 2025, TBIO is forecast to generate $3,395,002,055 in revenue, with the lowest revenue forecast at $3,395,002,055 and the highest revenue forecast at $3,395,002,055.